Huapont Life Sciences Hits Day Low at CNY 4.78 Amid Price Pressure

Huapont Life Sciences Co., a midcap player in the Chemicals & Petrochemicals industry, experienced a notable decline today, with its stock price dropping by 5.68% on March 23, 2026. The stock reached an intraday low of CNY 4.78, reflecting a challenging trading session. Over the past week, Huapont has seen a significant decrease of 12.84%, while its performance over the last month shows a decline of 10.07%. In contrast, the China Shanghai Composite index fell by 6.65% and 6.58% over the same periods, indicating that Huapont's downturn is more pronounced than the broader market. Despite a year-to-date gain of 0.84%, Huapont's longer-term performance reveals a more complex picture. The stock has declined by 11.56% over three years and 9.23% over five years, with a staggering 53.2% drop over the past decade. The company has reported a growth in net profit of 9.43% recently, but its operating profit has faced challenges, declining by 23.59% over the last five years. With a market capitalization of CNY 10,075 million, Huapont continues to navigate a competitive landscape marked by high debt levels and fluctuating profitability.